Abstract:Acute myocarditis encompasses a diverse presentation of inflammatory cardiomyopathies with infectious and non-infectious triggers. The clinical presentation is heterogeneous, from subtle symptoms like mild chest pain to life-threatening fulminant heart failure requiring urgent advanced hemodynamic support. This review provides a comprehensive overview of the current state of knowledge regarding the pathogenesis, diagnostic approach, management strategies, and directions for future research in acute myocarditis. The pathogenesis of myocarditis involves interplay between the inciting factors and the subsequent host immune response. Infectious causes, especially cardiotropic viruses, are the most frequently identified precipitants. However, autoimmune processes independent of microbial triggers, as well as toxic myocardial injury from drugs, chemicals or metabolic derangements also contribute to the development of myocarditis through diverse mechanisms. Furthermore, medications like immune checkpoint inhibitor therapies are increasingly recognized as causes of myocarditis. Elucidating the nuances of viral, autoimmune, hypersensitivity, and toxic subtypes of myocarditis is key to guiding appropriate therapy. The heterogeneous clinical presentation coupled with non-specific symptoms creates diagnostic challenges. A multifaceted approach is required, incorporating clinical evaluation, electrocardiography, biomarkers, imaging studies, and endomyocardial biopsy. Cardiovascular magnetic resonance imaging has become pivotal for non-invasive assessment of myocardial inflammation and fibrosis. However, biopsy remains the gold standard for histological classification and definitively establishing the underlying etiology. Management relies on supportive care, while disease-specific therapies are limited. Although some patients recover well with conservative measures, severe or fulminant myocarditis necessitates aggressive interventions such as mechanical circulatory support devices and transplantation. While immunosuppression is beneficial in certain histological subtypes, clear evidence supporting antiviral or immunomodulatory therapies for the majority of acute viral myocarditis cases remains insufficient. Substantial knowledge gaps persist regarding validated diagnostic biomarkers, optimal imaging surveillance strategies, evidence-based medical therapies, and risk stratification schema. A deeper understanding of the immunopathological mechanisms, rigorous clinical trials of targeted therapies, and longitudinal outcome studies are imperative to advance management and improve the prognosis across the myocarditis spectrum.

The current diagnosis and treatment of myocarditis

A case report on transient global ventricular wall thickening secondary to acute myocarditis Focus on the unique role of cardiac MRI

Performance of Cardiovascular Magnetic Resonance Strain in Patients with Acute Myocarditis

The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy

Diagnosis and Management of Myocarditis in Children: A Scientific Statement From the American Heart Association

Diagnosis and Treatment of Acute Myocarditis: A Review

Acute myocarditis: an overview of pathogenesis, diagnosis and management

Immunopathogenesis and immunomodulatory therapy for myocarditis

New Trends in the Development of Treatments of Viral Myocarditis

Update on Myocarditis: From Etiology and Clinical Picture to Modern Diagnostics and Methods of Treatment

Viral myocarditis: From molecular mechanisms to therapeutic prospects

Viral Myocarditis: Classification, Diagnosis, and Clinical Implications

Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis

Diagnosis and treatment of myocarditis and inflammatory cardiomyopathy. Consensus document of the SEC-Working Group on Myocarditis

14 A Life Support-Based Comprehensive Treatment Regimen Dramatically Reduced In-Hospital Mortality of Fulminant Myocarditis Patients

Diagnosis and treatment of eosinophilic myocarditis

Chinese Society of Cardiology guidelines on the diagnosis and treatment of adult fulminant myocarditis

Current treatment and immunomodulation strategies in Acute Myocarditis

Role of cardiovascular magnetic resonance imaging (CMR) in the diagnosis of acute and chronic myocarditis

Immune checkpoint inhibitor-related myocarditis: current understanding and potential diagnostic and therapeutic strategies

Fulminant Myocarditis: When One Size Does Not Fit All – A Critical Review of the Literature